San Francisco, California, Sept ,06 2018: According to a recent market research report by TMR Research, the global market for extracellular matrix (ECM) patches has been gaining pace owing to the rising numbers of trauma cases and the vast rise in prevalence of congenital heart diseases across the globe. The report is titled “Extracellular Matrix (ECM) Patches Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018–2028.”
Get Sample Copy of this Report @
Trauma cases often require repair and reconstruction procedures, leading to the increased demand for products that are capable of providing biochemical and structural support to cells damaged due to traumatic injuries to the body. According to the Centers for Disease Control and Prevention, thousands of babies are born with congenital heart diseases every year in the U.S. alone; the number of babies born with such conditions run in hundreds of thousands across the globe. The scenario has necessitated the increased development and availability of innovative biological patches for the effective treatment of the target ailment. The market has also benefitted from the rising usage of extracellular matrix in hernia and pelvic reconstruction surgeries in the past few years.
Geographically, the market for extracellular patches in North America accounts for the lion’s share in the overall market owing to the well-established healthcare industry, high numbers of trauma cases, increased prevalence of cardiovascular diseases, and high expenditure on healthcare. The market in North America also benefits from the vast funds allotted to the R&D sector and the easy availability of advanced products. The market in Asia Pacific also shows immense growth promise owing to steadily improving healthcare facilities and a thriving medical tourism industry in emerging economies in the region.
Read Comprehensive Overview of Report @
Some of the leading companies operating in the global extracellular matrix patches market are Coloplast, Aziyo Biologics, Baxter, Boston Scientific Corporation, and DSM.